● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Historically, the company has been releasing figures that are above expectations.
Weaknesses
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The firm trades with high earnings multiples: 24.43 times its 2021 earnings per share.
● The company's enterprise value to sales, at 4 times its current sales, is high.
● The company is highly valued given the cash flows generated by its activity.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.